on Cheplapharm Arzneimittel GmbH (isin : DE000CHP2222)
Caroline Jacquin appointed Managing Director of CHEPLAPHARM France SAS
On April 3, 2024, CHEPLAPHARM Arzneimittel GmbH announced Caroline Jacquin as the new Managing Director for its French subsidiary, CHEPLAPHARM France SAS, based in Levallois-Perret. She succeeds Isabelle Dalle, who is retiring but will provide advisory services to the company until year-end.
Jacquin, a seasoned pharmaceutical manager with a 25-year career spanning leadership roles in France, Singapore, and Mexico, comes from her latest position at MSD France. Her international experience and profound knowledge of the French market were highlighted as instrumental for the role. Jacquin's appointment is seen as a significant asset to CHEPLAPHARM France and its operations within the larger group.
Edeltraud Lafer, CEO of CHEPLAPHARM Arzneimittel GmbH, expressed gratitude towards the outgoing Director, Isabelle Dalle, for her pioneering work since 2016 and welcomed Jacquin's strategic prowess, anticipating further growth and success for the subsidiary under her leadership.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Cheplapharm Arzneimittel GmbH news